Presentation
Charing Cross Symposium 2026
EmboSci CMO Dr Frank R. Arko, III, MD introduces a large-vessel embolization device in development, exploring its potential application in aortic dissection and aortic aneurysm.
Pioneering a new class of
polymer embolic devices
Technology
Space-filling
polymer embolization
EmboSci is an Australia-based medical technology company developing the next generation of embolization technology. Our platform delivers discrete, x-ray visible polymer units that fill the vessel lumen for durable mechanical occlusion, independent of clot formation. The design goal - immediate, complete and predictable occlusion.
Volume
Large volume polymer units, delivered by a single catheter.
Versatility
Highly conformable to irregular shapes, fills tortuous vessels completely.
Visibility
Durable, traceable, and permanently visible under fluoroscopy.
A paradigm shift in embolization therapy
News
EmboSci's latest news
and research
Team
The team
EmboSci is a medical technology company advancing embolization beyond thrombosis.
Founded by engineers and clinicians specializing in endovascular innovation, we are developing a new class of embolic system to meet the unmet clinical needs in vascular surgery and interventional radiology.
Founders
Ashish Mitra
Founder, CEO & Director
- Founder & CEO, Endoluminal Sciences, Sydney, Australia.
- Medtronic Cardiovascular R&D, Santa Rosa, CA and Santa Ana, CA, USA.
- Stanford Biodesign, Stanford University, USA.
Mike Dake, MD
Cofounder
- Professor and Sr. Vice President, University of Arizona Health Sciences, USA.
- Professor and Director, Cardiothoracic Surgery, Stanford University Medical Centre, USA.
- President, Society of Interventional Radiology.
Frank Arko, MD
Cofounder & CMO
- Chief, Vascular and Endovascular surgery, Sanger Heart and Vascular Institute, NC, USA.
- Chief, Endovascular surgery, University of Texas Southwestern Medical Centre, USA.
- Stanford University and Texas A&M University, USA.
Board
Donal O'Dwyer
Chairman
- Worldwide President, Cordis / J&J.
- President, Baxter EU.
- Board of Directors: Cochlear, Mesoblast, Fisher & Paykel Healthcare and NIB Health.
Greg Plamondon
Director
- COO, Saluda Medical, Denver, CO, USA.
- CFO, Saluda Medical, Sydney, Australia.
- Sr. Vice President, Finance, Cochlear, Sydney, Australia.
Jeff Elkins
Director
- CEO, Veniti and Aptus EndoSystems. USA.
- Founder, FlowMedica. USA.
- Medtronic Endovascular, Cordis Endovascular and Haemonetics. USA.
Contact Us
Collaborate with us
We are actively engaging with strategic partners, clinicians, scientists, and investors to accelerate the next generation of embolization technologies.
Contact the team→